Literature DB >> 32738888

Role of HPV 16 variants among cervical carcinoma samples from Northeastern Brazil.

Rodrigo Lopes da Silva1, Zulmira da Silva Batista1, Gerusinete Rodrigues Bastos1, Ana Paula Almeida Cunha1, Fábio Vidal Figueiredo1, Lailson Oliveira de Castro2, Liwerbeth Dos Anjos Pereira2, Marcos Antonio Custódio Neto da Silva3, Flávia Castello Branco Vidal1, Maria Claudene Barros4, Elmary da Costa Fraga4, Luciane Maria Oliveira Brito1, Maria do Carmo Lacerda Barbosa1, Miguel Ângelo Martins Moreira5, Maria do Desterro Soares Brandão Nascimento6.   

Abstract

BACKGROUND: Cervical cancer is the fourth most common type of cancer affecting women globally. In Brazil, it is the third most frequent type of cancer in women and HPV is present in approximately 90% of cases. Evidence suggests that variants of HPV 16 can interfere biologically and etiologically during the development of cervical cancer.
METHODS: Cervix tumor fragments were collected, their DNA was extracted, and nested PCR was used to detect HPV. Positive samples were sequenced to determine the viral genotype. To characterize the HPV 16 strains, positive samples PCR was used to amplify the LCR and E6 regions of the HPV 16 virus.
RESULTS: Data from 120 patients with cervical cancer were analyzed. Most women were between 41 and 54 years of age, had schooling until primary school, a family income between 1 and 2 times the minimum wage and were married/in a consensual union. There was no statistically significant association between HPV or socio-demographic variables and risk factors for cervical cancer (P <  0.05). HPV was present in 88 women (73%). The most prevalent types were HPV 16 (53.4%), HPV 18 (13.8%), HPV 35 (6.9%) and HPV 45 (5.7%). Of the 47 HPV 16 positive cases, variant A (49%) was present in 23 samples, followed by variant D in 20 cases (43%), and variants B and C in 2 cases each (4%). The most prevalent histological type of HPV 16 tumors was squamous cell carcinoma, followed by adenocarcinoma. There was a statistically significant association between HPV 16 variants and the tumors' histological types (P <  0.001).
CONCLUSIONS: Knowledge of HPV 16 variants will provide data on their influence on the pathological and oncogenic aspects of cervical lesions.

Entities:  

Keywords:  Cervical cancer; HPV 16; Human papillomavirus; Variants

Year:  2020        PMID: 32738888      PMCID: PMC7395427          DOI: 10.1186/s12905-020-01035-0

Source DB:  PubMed          Journal:  BMC Womens Health        ISSN: 1472-6874            Impact factor:   2.809


  28 in total

Review 1.  Cervical cancer screening in the era of HPV vaccination: A review of shifting paradigms in cytopathology.

Authors:  Julieta E Barroeta; Deepti Adhikari-Guragain; Carolyn E Grotkowski
Journal:  Diagn Cytopathol       Date:  2017-06-06       Impact factor: 1.582

Review 2.  Genome variation of human papillomavirus types: phylogenetic and medical implications.

Authors:  Hans-Ulrich Bernard; Itzel E Calleja-Macias; S Terence Dunn
Journal:  Int J Cancer       Date:  2006-03-01       Impact factor: 7.396

Review 3.  The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses.

Authors:  Hans-Ulrich Bernard
Journal:  J Clin Virol       Date:  2005-03       Impact factor: 3.168

4.  Differential HPV16 variant distribution in squamous cell carcinoma, adenocarcinoma and adenosquamous cell carcinoma.

Authors:  S Nicolás-Párraga; L Alemany; S de Sanjosé; F X Bosch; I G Bravo
Journal:  Int J Cancer       Date:  2017-03-01       Impact factor: 7.396

5.  Human Papillomavirus 18 Genetic Variation and Cervical Cancer Risk Worldwide.

Authors:  Alyce A Chen; Tarik Gheit; Silvia Franceschi; Massimo Tommasino; Gary M Clifford
Journal:  J Virol       Date:  2015-08-12       Impact factor: 5.103

6.  Epidemiological patterns of cervical human papillomavirus infection among women presenting for cervical cancer screening in North-Eastern Nigeria.

Authors:  Mohammed Mohammed Manga; Adeola Fowotade; Yusuf Mohammed Abdullahi; Aliyu Usman El-Nafaty; Danladi Bojude Adamu; Hamidu Umar Pindiga; Rasheed Ajani Bakare; Abimbola Olu Osoba
Journal:  Infect Agent Cancer       Date:  2015-10-02       Impact factor: 2.965

7.  Prevalence of human papillomavirus infection and phylogenetic analysis of HPV-16 E6 variants among infected women from Northern Brazil.

Authors:  Bruna Pedroso Tamegão-Lopes; Rodrigo Vellasco Duarte Silvestre; Edivaldo Costa Sousa-Júnior; Fabio Passetti; Carlos Gil Ferreira; Wyller Alencar de Mello
Journal:  Infect Agent Cancer       Date:  2014-08-05       Impact factor: 2.965

Review 8.  Human papillomavirus molecular biology and disease association.

Authors:  John Doorbar; Nagayasu Egawa; Heather Griffin; Christian Kranjec; Isao Murakami
Journal:  Rev Med Virol       Date:  2015-03       Impact factor: 6.989

9.  Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer.

Authors:  Ana Alfaro; Eligia Juárez-Torres; Ingrid Medina-Martínez; Norma Mateos-Guerrero; Maura Bautista-Huerta; Edgar Román-Bassaure; Nicolás Villegas-Sepúlveda; Jaime Berumen
Journal:  PLoS One       Date:  2016-12-30       Impact factor: 3.240

10.  Human Leukocyte Antigen Class I and Class II Polymorphisms and Serum Cytokine Profiles in Cervical Cancer.

Authors:  Larissa Bahls; Roger Yamakawa; Karina Zanão; Daniela Alfieri; Tamires Flauzino; Francieli Delongui; André de Abreu; Raquel Souza; Fabrícia Gimenes; Edna Reiche; Sueli Borelli; Marcia Consolaro
Journal:  Int J Mol Sci       Date:  2017-08-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.